Recent studies have indicated that CHEK2 functions as a moderately effective cancer susceptibility gene; mutations in CHEK2 predispose individuals to breast cancer [7-10] as well cancer of other sites [11-13]. This evidence concerns the gene CHEK2 and breast carcinoma.